Oramed appoints Roy Eldor as chief medical director
Dr. Eldor is an endocrinologist, internist and researcher with over twenty years of clinical and scientific experience. He is currently Director of the Diabetes Unit at the Institute of Endocrinology, Metabolism & Hypertension, Tel-Aviv Sourasky Medical Center.
Prior to that, Dr. Eldor served as Principal Scientist at Merck Research Laboratories, Clinical Research – Diabetes & Endocrinology, Rahway, New Jersey.
He has previously served as a senior physician in internal medicine at the Diabetes Unit in Hadassah Hebrew University Hospital, Jerusalem, Israel; the Diabetes Division at the University of Texas Health Science Center in San Antonio, Texas (under the guidance of Dr. R.A. DeFronzo).
Dr. Eldor is a recognized expert, with over 35 peer reviewed papers and book chapters and has been an invited speaker to numerous international forums. ■
LATEST MOVES FROM Israel
- Teva appoints Kåre Schultz as CEO
- Immune Pharma appoints Tony Fiorino as COO
- Enzymotec appoints Dror Israel as CFO
- Intec Pharma appoints Jeffrey A. Meckler as CEO
- Foamix Pharmaceuticals names David Domzalski as CEO
More inside POST